Indiana University School Of Medicine

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1903-01-01

Employees: -

Market Cap: -

Website: http://www.medicine.iu.edu

Clinical Trials

Magnetic Resonance Imaging of the Brain and Stomach in Healthy Volunteers and Gastroparesis

Not Applicable

Active, not recruiting

Conditions: Gastroparesis

Interventions: Other: MRI scan

First Posted Date: 2020-02-24

Last Posted Date: 2024-04-12

Lead Sponsor: Indiana University School of Medicine

Target Recruit Count: 31

Registration Number: NCT04282317

Locations: 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States

Vitamin E for NASH Treatment in HIV Infected Individuals

Phase 2

Terminated

Conditions: NAFLD
NASH - Nonalcoholic Steatohepatitis
HIV Infections

Interventions: Drug: Vitamin E
Drug: Placebo

First Posted Date: 2018-09-13

Last Posted Date: 2023-07-25

Lead Sponsor: Indiana University School of Medicine

Target Recruit Count: 3

Registration Number: NCT03669133

Locations: 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia

Not Applicable

Terminated

Conditions: Intermittent Exotropia

Interventions: Device: CIAO therapy Amblyz glasses

First Posted Date: 2015-06-09

Last Posted Date: 2017-11-30

Lead Sponsor: Indiana University School of Medicine

Target Recruit Count: 8

Registration Number: NCT02466659

Locations: 🇺🇸
Glick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States

Effect of Bupivacaine-infused Fibrin Sealant Application on Post-tonsillectomy Pain & Hemorrhage

Phase 2

Terminated

Conditions: Pain, Postoperative
Postoperative Hemorrhage

Interventions: Biological: Fibrin Sealant
Drug: Bupivacaine

First Posted Date: 2015-01-21

Last Posted Date: 2018-08-10

Lead Sponsor: Indiana University School of Medicine

Target Recruit Count: 18

Registration Number: NCT02343263

Locations: 🇺🇸
Riley Childrens' Hospital, Indianapolis, Indiana, United States

Effects of Lacosamide on Post-operative Opioid Requirements After a Total Hip Arthroplasty:

Phase 2

Withdrawn

Conditions: Rheumatoid Arthritis
Osteoarthritis
Avascular Necrosis

Interventions: Drug: Placebo
Drug: Lacosamide

First Posted Date: 2015-01-21

Last Posted Date: 2016-08-26

Lead Sponsor: Indiana University School of Medicine

Registration Number: NCT02342977

Locations: 🇺🇸
Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana, United States

Comparison of a Bilateral TAP Block and Preperitoneal Instillation of Local Anesthetic for a Total Extraperitoneal (TEP) Repair

Not Applicable

Completed

Conditions: Bilateral Inguinal Hernia Repair

Interventions: Procedure: Transversus abdominis plane block (TAP BLOCK)
Procedure: Instillation of surgical site with local anesthetic.
Procedure: Opioid IV medications (Control)

First Posted Date: 2014-01-15

Last Posted Date: 2018-06-06

Lead Sponsor: Indiana University School of Medicine

Target Recruit Count: 75

Registration Number: NCT02036983

Locations: 🇺🇸
Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana, United States

Viral Pathogenesis of Early Cystic Fibrosis Lung Disease

Completed

Conditions: Cystic Fibrosis

First Posted Date: 2013-10-31

Last Posted Date: 2017-04-04

Lead Sponsor: Indiana University School of Medicine

Target Recruit Count: 65

Registration Number: NCT01973192

Locations: 🇺🇸
St. Louis Children's Hospital, St. Louis, Missouri, United States
🇺🇸
Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana, United States
🇦🇺
The Royal Children's Hospital, Melbourne, Victoria, Australia

and more 1 locations

Nitric Oxide to Treat Pulmonary Embolism

Phase 2

Completed

Conditions: Pulmonary Embolism

Interventions: Drug: Sham
Drug: Inhaled Nitric Oxide

First Posted Date: 2013-09-11

Last Posted Date: 2018-10-03

Lead Sponsor: Indiana University School of Medicine

Target Recruit Count: 78

Registration Number: NCT01939301

Locations: 🇺🇸
University of Mississippi, Jackson, Mississippi, United States
🇺🇸
Methodist Hospital, Indianapolis, Indiana, United States
🇺🇸
Eskenazi Hospital, Indianapolis, Indiana, United States

and more 1 locations

Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors

Phase 2

Terminated

Conditions: Adult Teratoma
Malignant Extragonadal Non-Seminomatous Germ Cell Tumor
Recurrent Malignant Testicular Germ Cell Tumor
Malignant Extragonadal Germ Cell Tumor
Stage IV Extragonadal Seminoma
Stage IV Ovarian Germ Cell Tumor
Adult Central Nervous System Germ Cell Tumor
Recurrent Ovarian Germ Cell Tumor
Extragonadal Seminoma
Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor

Interventions: Drug: palifosfamide

First Posted Date: 2013-03-11

Last Posted Date: 2015-07-02

Lead Sponsor: Indiana University School of Medicine

Target Recruit Count: 5

Registration Number: NCT01808534

Locations: 🇺🇸
Abramson Cancer Center of The University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Indiana University Cancer Center, Indianapolis, Indiana, United States
🇺🇸
Virginia Mason Medical Center, Seattle, Washington, United States

Early Diabetes Intervention Program

Phase 4

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Placebo
Drug: Acarbose

First Posted Date: 2011-11-11

Last Posted Date: 2011-11-11

Lead Sponsor: Indiana University School of Medicine

Target Recruit Count: 219

Registration Number: NCT01470937

Locations: 🇺🇸
Indiana University Hospital GCRC, Indianapolis, Indiana, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy